Gordon Wang, director of the Neuroscience Microscopy Service Community Lab at Wu Tsai Neuro, and his team are studying integrated stress response inhibitor (ISRIB) as a potential treatment for Fragile X syndrome, aiming to restore brain function and improve social behavior.